<unk>  is a glucagon-like peptide-2 (GLP-2) analog that is FDA approved for the treatment of short bowel syndrome (SBS) who are dependent on parenteral support.   Common adverse reactions include abdominal pain, injection site reactions, nausea, headaches, abdominal distension, upper respiratory tract infection.
Teduglutide
Semaglutide
Albiglutide
Dulaglutide
Liraglutide
Linagliptin
Saxagliptin
Exenatide